Articles by Michael A. Gollin - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Michael A. Gollin

Myriad Decision Places Biotech at a Crossroads

In light of the new ruling, patent licensees may want to re-evaluate the strength of their licensed patents.
Aug 1, 2010

In light of the new ruling, patent licensees may want to re-evaluate the strength of their licensed patents.

ADVERTISEMENT

ADVERTISEMENT

Click here